Sarda Proteins Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Sarda Proteins hat ein Gesamteigenkapital von ₹24.0M und eine Gesamtverschuldung von ₹0.0, was einen Verschuldungsgrad von 0% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen ₹24.1M bzw. ₹112.0K.

Wichtige Informationen

Verhältnis von Schulden zu Eigenkapital

₹0

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	₹2.32m
Eigenkapital	₹23.98m
Gesamtverbindlichkeiten	₹112.00k
Gesamtvermögen	₹24.09m

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: 519242Die kurzfristigen Aktiva des Unternehmens (₹22.7M) übersteigen seine kurzfristigen Passiva (₹112.0K).

Langfristige Verbindlichkeiten: 519242 hat keine langfristigen Verbindlichkeiten.

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: 519242 ist schuldenfrei.

Schulden abbauen: 519242 hatte vor 5 Jahren keine Schulden.

Schuldendeckung: 519242 hat keine Schulden und muss daher nicht durch den operativer Cashflow gedeckt werden.

Zinsdeckung: 519242 hat keine Schulden, daher ist die Deckung der Zinszahlungen kein Problem.

Sarda Proteins Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Recent updates

Sarda Proteins Ltd to Report Q2, 2025 Results on Nov 08, 2024

Sarda Proteins Ltd, Annual General Meeting, Sep 28, 2024

First quarter 2025 earnings released: ₹0.46 loss per share (vs ₹0.01 loss in 1Q 2024)

Sarda Proteins Ltd Announces Resignation of Mahavir Pratap Sharma as Independent Director, Effective August 11, 2024

Sarda Proteins Ltd Receives Resignation from Amit Kumar Modi as Company Secretary & Compliance Officer

Sarda Proteins Ltd Approves Board Changes

Sarda Proteins Ltd Announces Resignation of Shipra Gandhi as Chief Financial Officer

Sarda Proteins Ltd Appoints Khilan Hareshbhai Savaliya as Additional Director (Non-Executive)

Sarda Proteins Ltd Appoints Khilan Hareshbhai Savaliya as Additional Director (Non-Executive)

Less than half of directors are independent

Sarda Proteins Ltd Appoints Chirag Shantilal Thumar as Additional Executive Director

Sarda Proteins Ltd Appoints Chirag Shantilal Thumar as Additional Executive Director

MD & Director recently sold ₹3.0m worth of stock

Full year 2024 earnings released: EPS: ₹0.11 (vs ₹0.19 loss in FY 2023)

Sarda Proteins Ltd to Report Q4, 2024 Results on Apr 30, 2024

Sarda Proteins Ltd to Report Q4, 2024 Results on Apr 30, 2024

Insufficient new directors

Third quarter 2024 earnings released: EPS: ₹0.04 (vs ₹0.01 in 3Q 2023)

Sarda Proteins Ltd to Report Q3, 2024 Results on Feb 13, 2024

Sarda Proteins Ltd Announces Resignation of Somya Data as Chief Financial Officer

Second quarter 2024 earnings released: ₹0.03 loss per share (vs ₹0.02 profit in 2Q 2023)

Sarda Proteins Ltd to Report Q2, 2024 Results on Nov 07, 2023

Sarda Proteins Ltd, Annual General Meeting, Sep 29, 2023

Sarda Proteins Ltd to Report Q1, 2024 Results on Aug 14, 2023

New major risk - Share price stability

Full year 2023 earnings released: ₹0.19 loss per share (vs ₹1.78 profit in FY 2022)

Sarda Proteins Ltd to Report Q4, 2023 Results on May 30, 2023

Investor sentiment improves as stock rises 15%

Investor sentiment deteriorates as stock falls 16%

Insufficient new directors

Investor sentiment improves as stock rises 16%

Third quarter 2023 earnings released: EPS: ₹0.01 (vs ₹0.32 in 3Q 2022)

Sarda Proteins Ltd Announces Chief Financial Officer Changes

Sarda Proteins Ltd to Report Q3, 2023 Results on Jan 30, 2023

Sarda Proteins Ltd Announces Resignation of Himanshu Gupta as Chief Financial Officer, Effective 30 January 2023

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Second quarter 2023 earnings released: EPS: ₹0.02 (vs ₹0.14 loss in 2Q 2022)

Sarda Proteins Ltd to Report Q2, 2023 Results on Oct 19, 2022

Investor sentiment improved over the past week

Sarda Proteins Limited, Annual General Meeting, Sep 23, 2022

Investor sentiment improved over the past week

Sarda Proteins Limited to Report Q1, 2023 Results on Aug 05, 2022

Investor sentiment improved over the past week

Sarda Proteins Limited to Report Q4, 2022 Results on May 27, 2022

High number of new and inexperienced directors

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

High number of new and inexperienced directors

Full year 2021 earnings released: ₹0.12 loss per share (vs ₹0.19 profit in FY 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: ₹0.17 loss per share (vs ₹0.56 profit in 3Q 2020)

Sarda Proteins Ltd. to Report Q3, 2021 Results on Feb 12, 2021

Market bids up stock over the past week

Sarda Proteins Ltd. to Report Q2, 2021 Results on Nov 09, 2020

Sarda Proteins Ltd. to Report Q2, 2020 Results on Sep 02, 2020

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Entdecken Sie finanziell stabile Unternehmen